Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn & Co. AG increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 20,861 shares of the medical equipment provider's stock after buying an additional 552 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Intuitive Surgical were worth $10,889,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Summit Securities Group LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $30,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $31,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $35.45 on Friday, hitting $459.16. The stock had a trading volume of 1,813,384 shares, compared to its average volume of 1,534,203. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $163.54 billion, a price-to-earnings ratio of 71.57, a P/E/G ratio of 5.85 and a beta of 1.55. The stock's 50 day moving average is $547.83 and its 200-day moving average is $532.58.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Robert W. Baird cut their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a report on Tuesday, March 18th. CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective on the stock. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.